With more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept.
Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.
Quotient Sciences have the expertise to overcome the challenges that arise with handling highly potent API (HPAPI). Download our info sheet to learn more.
Providing expertise to support pre-formulation development. Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid-state characterization.
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
Quotient Sciences is dedicated to Phase I trials and early drug development, helping you accelerate your molecule from first-in-human (FIH) trials to proof of concept (POC). We focus on providing the insights you need by offering comprehensive clinical pharmacology services for all Phase I study programs.
Our services encompass expert clinical study design, thorough data analysis, and detailed reporting. With our fully integrated approach, we ensure seamless execution and deliver high-quality results safely and quickly.
From preclinical and first-in-human (FIH) dosage forms to optimization of your drug products for late stage development, we work with you to develop the most appropriate formulation.
We provide full service support for small molecule non-sterile programs, from dosage formulation development through to GMP clinical trial manufacturing and commercial drug product supply.
Quotient Sciences Translational Pharmaceutics® is our unique platform which accelerates drug development, trusted for more than 17 years. Global pharmaceutical and biotech companies have successfully used Translational Pharmaceutics® since 2008. Learn more about how it works.
Quotient Sciences is a leading expert in the application of physiologically based pharmacokinetic (PBPK) modelling and simulation (M&S) science to drug development. Using GastroPlus™ we advise our clients on the potential in vivo performance of drugs and formulations to inform product and clinical development strategies.